和黄医药（HCM）在夜盘交易中大涨5.34%，引发市场关注。这一显著涨幅可能与港股医药股整体走强以及南向资金持续增持有关。
根据市场数据，港股医药股板块今日表现强劲。信达生物涨超9%，翰森制药和联邦制药涨幅超过4%，和黄医药早些时候也录得超过2%的涨幅。这一板块性上涨可能是推动和黄医药股价夜盘走高的重要因素之一。
此外，南向资金对和黄医药的持续看好也可能助推了股价上涨。数据显示，3月26日南向资金增持和黄医药144.20万股，这已经是连续第4个交易日增持。截至当日收盘，港股通共持有和黄医药20552.54万股，占流通股的23.58%。这种持续的资金流入可能增强了投资者对该股的信心，进而推动股价上涨。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.